Survey: Cloud computing tops pharma's IT plans

Cloud computing isn't anything new in the pharma world, where drugmakers have used web-based storage, software and services for years. But from the looks of a recent Bio-IT World survey of 121 senior execs in life sciences, cloud computing has become pervasive in pharma organizations. With just under half of the respondents from pharma companies, the survey found that by a small majority cloud computing was the most common area of IT spending this year. Cloud storage was a spending priority for two thirds of respondents who plan to spend thousands on it, and 12% of the IT execs shell out over $300,000 per year on storing data in external data centers. Check out more IT trends from the publication's survey.  

Suggested Articles

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.

The $58 million financing round represents biopharma industry's growing interest in genomics data.

Clinerion inks a new deal that adds 60 million U.S. patients to its clinical trial patient recruitment system.